Optimi Health inks $100M equity line with Seven Knots
Optimi Health Corp. (OPTH) entered into a common share purchase agreement with Seven Knots, LLC, establishing an equity line of credit under which Optimi may, at its discretion, sell up to US$100 million of common shares over the term of the facility.
Rhea-AI Filing Summary
Optimi Health Corp. (OPTH) entered into a common share purchase agreement with Seven Knots, LLC, establishing an equity line of credit under which Optimi may, at its discretion, sell up to US$100 million of common shares over the term of the facility. For each draw, Seven Knots must buy the specified shares at 97% of the lower of the lowest sale price on the purchase date and the volume-weighted average price during the purchase period, with a maximum of US$2 million per draw and a price floor set at 85% of the prior day’s close or a higher Company-selected floor.
As consideration, Optimi issued Seven Knots a non-interest-bearing US$1.5 million unsecured convertible promissory note and agreed to issue a second US$500,000 note if gross ELOC sales reach US$7 million. These notes mature in 24 months and are convertible at 95% of the 20-day volume-weighted average price, with a minimum conversion price of US$3.00 per share and a 2.99% beneficial ownership cap. Optimi may prepay the notes at 100% of principal in cash, and no shares can be sold under the ELOC until a filed Form F-1 resale registration statement is declared effective by the SEC.
Positive
- US$100 million discretionary equity line of credit provides significant potential access to capital.
- Equity draws are capped at US$2 million per draw, allowing staged access rather than a single large issuance.
- Convertible notes include a US$3.00 per share floor and a 2.99% beneficial ownership cap, limiting extreme dilution from any single holder.
- Company can prepay the US$2.0 million in Commitment Notes at 100% of principal, which can eliminate further share issuance from those notes.
Negative
- The equity line permits issuance of up to US$100 million of common shares, creating potential for substantial equity dilution.
- Commitment financing involves a US$1.5 million convertible note and a possible additional US$500,000 note, both convertible at a 5% discount to 20-day VWAP.
- Shares sold under the ELOC will be priced at 97% of market reference prices, embedding a discount that may pressure trading levels.
- A Form F-1 registration for resale of shares issued under the Purchase Agreement and notes may create an overhang once effective.
Key Figures
Key Terms
equity line of credit financial
volume-weighted average price financial
convertible promissory note financial
beneficially own financial
registration statement on Form F-1 regulatory
FAQ
What financing agreement did Optimi Health Corp. (OPTH) enter into with Seven Knots?
What are the key terms of the convertible promissory notes issued by Optimi Health (OPTH)?
Is there a limit on how much of Optimi Health (OPTH) Seven Knots can own?
Can Optimi Health (OPTH) avoid dilution from the convertible notes with Seven Knots?
AI-generated analysis. How Rhea-AI works. Not financial advice.